Cholinergic white matter pathway degeneration is central in Alzheimer's disease and Lewy body disease and can be assessed in vivo using magnetic resonance imaging proxies, but neuropathological validation is limited.
Abstract
Cholinergic white matter pathway (CWMP) degeneration is central in Alzheimer's disease (AD) and Lewy body disease (LBD). CWMP degeneration can be assessed in vivo using magnetic resonance imaging (MRI) proxies, but neuropathological validation is limited.
This scientific commentary refers to ‘White matter lesions disrupt cholinergic pathways important for cognition in Parkinson’s disease’ by Carli et al. (https://doi.org/10.1093/brain/awag172).
Patrick Murphy, A. Zarkali, R. Weil· Brain : a journal of neurolo...· 0 citations
Cognitive impairment is an important non‐motor manifestation of amyotrophic lateral sclerosis (ALS), particularly across the ALS–frontotemporal dementia (ALS–FTD) spectrum. Cerebrospinal fluid (CSF) tau and amyloid biomarkers may reflect nonspecific neurodegenerative injury, concomitant Alzheimer disease (AD) pathology...
Aasim Ali, Muhammad Arif, Usama Ashraf et al.· Brain and Behavior· 0 citations
This scientific commentary refers to ‘Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes’ by Cullinane et al. (https://doi.org/10.1093/brain/awag131).
D. Thal, J. Schaeverbeke· Brain : a journal of neurolo...· 0 citations
White matter (WM), as the critical infrastructure for neural communication, is implicated in pediatric bipolar disorder (PBD) pathophysiology. However, the state‐specific abnormalities in the segmental structural and functional properties of adolescent fiber tracts remain unclear.
The dual syndrome hypothesis distinguishes frontostriatal and posterior cortical cognitive subtypes in Parkinson's disease with mild cognitive impairment (PD‐MCI), which are associated with distinct cognitive profiles and different risks of dementia.
Xue-Qin Bai, Hao-Xin Chen, Qiu-Yue Li et al.· European Journal of Neurolog...· 0 citations
We tested whether quantitative transport mapping (QTM)‐derived perfusion velocity would detect earlier and more sex‐specific microvascular alterations than cerebral blood flow (CBF) across the Alzheimer's disease (AD) continuum.
Man-Xi Xu, Yian Gao, Peiling Ou et al.· Alzheimer's & Dementia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.